Info: Read More
  • 中药标准品生产商,产品定制服务
  • 葫芦素D

    Cucurbitacin D

    葫芦素D
    产品编号 CFN90209
    CAS编号 3877-86-9
    分子式 = 分子量 C30H44O7 = 516.67
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Triterpenoids
    植物来源 The rhizomes of Hemsleya amabilis Diels.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    葫芦素D CFN90209 3877-86-9 1mg QQ客服:1457312923
    葫芦素D CFN90209 3877-86-9 5mg QQ客服:1457312923
    葫芦素D CFN90209 3877-86-9 10mg QQ客服:1457312923
    葫芦素D CFN90209 3877-86-9 20mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Funda??o Universitária de Desenvolvimento (Brazil)
  • Universiti Malaysia Pahang (Malaysia)
  • University of Leipzig (Germany)
  • Universite de Lille1 (France)
  • Hamdard University (India)
  • Universidad Miguel Hernández (Spain)
  • VIB Department of Plant Systems Biology, UGent (PSB) (Belgium)
  • University of Zurich (Switzerland)
  • Universidad de Buenos Aires (Argentina)
  • Julius Kühn-Institut (Germany)
  • Uniwersytet Medyczny w ?odzi (Poland)
  • Molecular Biology Institute of Barcelona (IBMB)-CSIC (Spain)
  • Universitas islam negeri Jakarta (Indonesia)
  • St. Jude Children Research Hospital (USA)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • ACS Pharmacol. Transl. Sci.2023, 3c00129.
  • Molecules.2021, 26(8):2161.
  • Antioxidants (Basel).2021, 10(8):1300.
  • Arch Biochem Biophys.2018, 644:93-99
  • Univerzita Karlova2021, 20.500.11956.
  • J Ethnopharmacol.2019, 241:112025
  • Food Chem.2021, 377:131976.
  • Bioorg Med Chem.2020, 28(12):115553.
  • Front Plant Sci.2022, 13:982771.
  • PLoS One.2020, 15(2):e0220084.
  • Molecules.2023, 28(7):3039.
  • Univerzita Karlova2022, 173245.
  • Food Funct.2022, 13(14):7638-7649.
  • J. Korean Wood Sci. Technol.2022, 50(5):338-352.
  • J Drug Delivery Science and Tech.2022, 67:102957.
  • Antioxidants (Basel).2020, 9(6):544.
  • Environ Toxicol.2019, 34(4):513-520.
  • Molecules.2019, 24(20):3755
  • J Agric Food Chem.2021, 69(11):3496-3510.
  • RSC Advances2017, 86
  • Front Pharmacol.2018, 9:756
  • Plant Cell,Tissue & Organ Culture2016, 127(1):115-121
  • Toxins (Basel).2021, 13(9):593.
  • ...
  • 生物活性
    Description: Cucurbitacin D has anticancer effects, it induces apoptosis through caspase-3 and phosphorylation of JNK in hepatocellular carcinoma cells. Cucurbitacin D may be a potential therapeutic agent for β-hemoglobinopathies, including sickle cell anemia and β-thalassemia. Cucurbitacin D is a new inflammasome activator in macrophages, it can initiate immunomodulating activity in macrophages to lead to inflammasome activation as well as enhancement of LPS signaling.
    Targets: IL Receptor | JNK | STAT | NF-kB | Caspase | ERK | CDK | p38MAPK
    In vitro:
    Int Immunopharmacol. 2013 Dec;17(4):1044-50.
    Cucurbitacin D is a new inflammasome activator in macrophages.[Pubmed: 24140411]
    We previously reported that cucurbitacin D isolated from Trichosanthes kirilowii has anti-tumor roles to leukemia cells. However, the effect of cucurbitacin D on immune cells is not fully understood although there is no toxic activity to normal cells.
    METHODS AND RESULTS:
    In this study, immunomodulating activities of cucurbitacin D were investigated in macrophages. Cucurbitacin D could increase LPS-induced interleukin (IL)-1β production in culture supernatant of THP-1 cells, peritoneal exudate cells (PECs), bone marrow derived macrophages (BMDMs), and RAW264 cells. At the transcriptional level, cucurbitacin D enhanced LPS-induced IL-1β mRNA expression through activation of ERK1/2 mitogen-activated protein kinases (MAPKs). At the posttranscriptional level, the activation of caspase-1 induced by cucurbitacin D has also been demonstrated following treatment with a caspase-1 inhibitor and siRNA. Importantly, cucurbitacin D has further been shown to induce inflammasome activation independent of ERK1/2 activation. Western blotting showed interaction of NOD-like receptor family, pyrin domain containing 3 (NALP3) and apoptosis-associated speck-like protein containing a caspase-activating and recruitment domain (ASC), suggesting activation of the inflammasome and a possible reason for activation of caspase-1.
    CONCLUSIONS:
    Taken together, these results suggest that cucurbitacin D could initiate immunomodulating activity in macrophages to lead to inflammasome activation as well as enhancement of LPS signaling.
    Anticancer Res. 2014 Sep;34(9):4797-806.
    Cucurbitacin-D-induced CDK1 mRNA up-regulation causes proliferation arrest of a non-small cell lung carcinoma cell line (NSCLC-N6).[Pubmed: 25202060]
    Despite progress in chemotherapeutic agents, non-small cell lung cancers (NSCLC) still have a poor survival rate. Thus, development of new therapeutic strategies, specifically against cancer cells is still required.
    METHODS AND RESULTS:
    For this purpose, we treated the non-small cell lung cancer cell line NSCLC-N6 with the natural product Cucurbitacin D (CucD) - extracted from the plant Ecballium elaterium in order first to assess its in vitro cytotoxicity, but also to study the genetic changes that it could bring out. Cucurbitacin D has shown a blocking in the G1 phase of the cell cycle in NSCLC-N6 cells prior to apoptotic cell death. The reverse transcriptase-polymerase chain reaction-differential display (RT-PCR-DD) technique was also applied on treated cells to elucidate the genetic mechanisms involved. We revealed an overexpression of Cyclin-dependent kinase 1 (CDK1) mRNA after treatment and, with the use of antisense oligonucleotides, an effective role in the proliferation arrest of NSCLC-N6 cells.
    CONCLUSIONS:
    The present study provides new insights about the mechanisms of proliferation arrest in tumor cells and open new ways of treatment to target tumor growth.
    Int Immunopharmacol. 2009 Apr;9(4):508-13.
    Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro.[Pubmed: 19185617]
    The aim of the present study is to examine the effects of the anti-tumor component isolated from Trichosanthes kirilowii on human hepatocellular carcinoma cells.
    METHODS AND RESULTS:
    Using Sephadex G-25 column chromatography, Sep-Pak Plus C18 cartridge and high-performance liquid chromatography (HPLC), we isolated the active component from trichosanthes extract. By fast atom bombardment mass spectrometric analysis, the molecular mass of the active fraction was determined, the active components identified, and their mechanisms of action were analyzed by cell growth assay, cell cycle analysis, TUNEL staining and Western blot analysis. We found that the anti-tumor components isolated from the extract of trichosanthes (EOT) are cucurbitacin D and dihydrocucurbitacin D, and suggest that cucurbitacin D induces apoptosis through caspase-3 and phosphorylation of JNK in hepatocellular carcinoma cells.
    CONCLUSIONS:
    These results suggest that cucurbitacin D isolated from Trichosanthes kirilowii could be a valuable candidate for anti-tumor drug.
    In vivo:
    Blood Cells Mol Dis. 2010 Dec 15;45(4):269-75.
    Cucurbitacin D induces fetal hemoglobin synthesis in K562 cells and human hematopoietic progenitors through activation of p38 pathway and stabilization of the γ-globin mRNA.Cucurbitacin D induces fetal hemoglobin synthesis in K562 cells and human hematop[Pubmed: 20926322]
    The search for novel therapeutic candidates targeting fetal hemoglobin (HbF) activation to reduce the imbalance of globin genes is regarded as a promising approach for the clinical management of sickle cell disease and β-thalassemia.
    METHODS AND RESULTS:
    For the first time, we identified Cucurbitacin D (CuD), an oxygenated tetracyclic triterpenoid, as a molecular entity inducing γ-globin gene expression and HbF synthesis in K562 cells and human hematopoietic progenitors from a β-thalassemia patient. Cucurbitacin D demonstrated a higher potency in HbF induction when compared with hydroxyurea, which was revealed by the evidence that Cucurbitacin D results in a higher fetal cell percentage and greater HbF content in K562 cells, in addition, to being less cytotoxic. Moreover, Cucurbitacin D also promotes higher HbF expression in primary erythroid cells. In the study to elucidate the molecular mechanisms of Cucurbitacin D's action, our data indicated that Cucurbitacin D-stimulated HbF synthesis was mediated by p38 pathway activation. At the post-transcriptional level, Cucurbitacin D treatment led to a significant elongation of the γ-globin mRNA half-life in K562 cells.
    CONCLUSIONS:
    Taken together, the results suggest that Cucurbitacin D may be a potential therapeutic agent for β-hemoglobinopathies, including sickle cell anemia and β-thalassemia.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 1.9355 mL 9.6774 mL 19.3547 mL 38.7094 mL 48.3868 mL
    5 mM 0.3871 mL 1.9355 mL 3.8709 mL 7.7419 mL 9.6774 mL
    10 mM 0.1935 mL 0.9677 mL 1.9355 mL 3.8709 mL 4.8387 mL
    50 mM 0.0387 mL 0.1935 mL 0.3871 mL 0.7742 mL 0.9677 mL
    100 mM 0.0194 mL 0.0968 mL 0.1935 mL 0.3871 mL 0.4839 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    二氢葫芦素B; Dihydrocucurbitacin B CFN92140 13201-14-4 C32H48O8 = 560.7 10mg QQ客服:1457312923
    法巴森; Fabacein CFN91586 37710-13-7 C34H48O9 = 600.7 5mg QQ客服:215959384
    Arvenin II; Arvenin II CFN92896 65247-28-1 C38H58O13 = 722.86 5mg QQ客服:2056216494
    Arvenin III; Arvenin III CFN95327 65597-45-7 C36H54O12 = 678.8 5mg QQ客服:1457312923
    葫芦苦素D; Hexanorcucurbitacin D CFN92893 29065-05-2 C24H34O5 = 402.52 5mg QQ客服:2159513211
    葫芦素D; Cucurbitacin D CFN90209 3877-86-9 C30H44O7 = 516.67 10mg QQ客服:2056216494
    异葫芦素 D; Isocucurbitacin D CFN95326 68422-20-8 C30H44O7 = 516.7 5mg QQ客服:1457312923
    23,24-二氢异葫芦素 B; 23,24-dihydroisocucurbitacin B CFN92894 68354-21-2 C32H48O8 = 560.72 5mg QQ客服:1413575084
    异葫芦素 B; Isocucurbitacin B CFN91003 17278-28-3 C32H46O8 = 558.7 10mg QQ客服:2159513211
    葫芦素B; Cucurbitacin B CFN99129 6199-67-3 C32H46O8 = 558.70 20mg QQ客服:2056216494

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产